James Healy, Director at Rapport Therapeutics, Inc. (RAPP), bought 1,951,562 shares at $17.00 ($9.5M) on 2024-06-10, disclosed to the SEC on 2024-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,392,738 | $0 | 0.0% |
| 2 | $17.00 | 17,861 | $304K | 3.2% |
| 3 | $17.00 | 18,641 | $317K | 3.3% |
| 4 | $17.00 | 25,455 | $433K | 4.6% |
| 5 | $17.00 | 26,278 | $447K | 4.7% |
| 6 | $17.00 | 470,589 |
| $8.0M |
| 84.2% |
| Total | $4.87 avg | 1,951,562 | $9.5M | 100% |
| Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |
| CINC | SELL | 2023-02-27 | $86K | — | Filing → |